|
5 results found.
|
Renishaw Diagnostics signs exclusive licence agreement for SERRS Beacons with The University of Strathclyde
Renishaw Diagnostics Ltd, today announced that it has concluded an exclusive licence agreement to a patent on nucleic acid sequence identification (SERRS beacons) from The University of Strathclyde.David Burns, CEO said “We are very pleased to have secured this licence for such an important piece of intellectual property. Although we have just launched our first major product, the RenDx™ Multiplex Analysis System for research use only in infectious diseases, we are already looking to devel [17 kB]
CollaborationsCollaborations- [80 x 81 pixels] [2 kB]
- [180 x 183 pixels] [5 kB]
- [217 x 221 pixels] [15 kB]
CollaborationsGeneric collaboration representation - [180 x 180 pixels] [7 kB]
|
|